Oxytocin and bone remodelling: Relationships with neuropituitary hormones, bone status and body composition

Joint Bone Spine

Volumn 78, Issue 6, 2011, Pages 611-615

  Breuil, Véronique ^a,b   Amri, Ez Zoubir ^b   Panaia Ferrari, Patricia ^c   Testa, Jean ^a   Elabd, Christian ^b   Albert Sabonnadière, Christine ^a   Roux, Christian Hubert ^a   Ailhaud, Gérard ^b   Dani, Christian ^b   Carle, Georges F ^b   Euller Ziegler, Liana ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c University Hospital of Nice University of Nice Sophia Antipolis   (France)

Author keywords

Body composition; Estradiol; Leptin; Oxytocin; Postmenopausal osteoporosis

Indexed keywords

ESTRADIOL; ESTROGEN; LEPTIN; NEUROHYPOPHYSIS HORMONE; OXYTOCIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MINERAL; BONE REMODELING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HUMAN; NEUROHYPOPHYSIS; OSTEOPOROSIS; OXYTOCIN RELEASE; PATHOPHYSIOLOGY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS;

AGED; AGED, 80 AND OVER; BODY COMPOSITION; BONE DENSITY; BONE REMODELING; CASE-CONTROL STUDIES; COLLAGEN TYPE I; ESTRADIOL; FEMALE; HUMANS; LEPTIN; LUTEINIZING HORMONE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OXYTOCIN; PEPTIDES; PITUITARY HORMONES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX HORMONE-BINDING GLOBULIN;

EID: 81355162281     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.02.002     Document Type: Article

References (37)

1. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2:35-43.
2. Muruganandan S., Roman A.A., Sinal C.J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009, 66:236-253.
3. Gimpl G., Fahrenholz F The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001, 81:629-683.
4. Du Vigneaud V., Ressler C., Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem 1953, 205:949-957.
5. Nickerson K., Bonsness R.W., Douglas R.G., et al. Oxytocin and milk ejection. Am J Obstet Gynecol 1954, 67:1028-1034.
6. Arletti R., Benelli A., Bertolini A Oxytocin inhibits food and fluid intake in rats. Physiol Behav 1990, 48:825-830.
7. Miedlar J.A., Rinaman L., Vollmer R.R., et al. Oxytocin gene deletion mice overconsume palatable sucrose solution but not palatable lipid emulsions. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1063-R1068.
8. Blevins J.E., Schwartz M.W., Baskin D.G. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am J Physiol Regul Integr Comp Physiol 2004, 287:R87-R96.
9. Camerino C Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 2009, 17:980-984.
10. Ducy P., Amling M., Takeda S., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000, 100:197-207.
11. Copland J.A., Ives K.L., Simmons D.J., et al. Functional oxytocin receptors discovered in human osteoblasts. Endocrinology 1999, 140:4371-4374.
12. Colucci S., Colaianni G., Mori G., et al. Human osteoclasts express oxytocin receptor. Biochem Biophys Res Commun 2002, 297:442-445.
13. Elabd S.K., Sabry I., Hassan W.B., et al. Possible neuroendocrine role for oxytocin in bone remodeling. Endocr Regul 2007, 41:131-141.
14. Elabd C., Basillais A., Beaupied H., et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 2008, 26:2399-2407.
15. Tamma R., Colaianni G., Zhu L.L., et al. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A 2009, 106:7149-7154.
16. Honda K., Narita K., Murata T., et al. Leptin affects the electrical activity of neurones in the hypothalamic supraoptic nucleus. Brain Res Bull 2002, 57:721-725.
17. Sirotkin A.V., Mlyncek M., Kotwica J., et al. Leptin directly controls secretory activity of human ovarian granulosa cells: possible inter-relationship with the IGF/IGFBP system. Horm Res 2005, 64:198-202.
18. Sun L., Davies T.F., Blair H.C., et al. TSH and bone loss. Ann N Y Acad Sci 2006, 1068:309-318.
19. Sun L., Peng Y., Sharrow A.C., et al. FSH directly regulates bone mass. Cell 2006, 125:247-260.
20. McCann S.M., Kimura M., Walczewska A., et al. Hypothalamic control of gonadotropin secretion by LHRH, FSHRF, NO, cytokines, and leptin. Domest Anim Endocrinol 1998, 15:333-344.
21. Martini G., Valenti R., Giovani S., et al. Age-related changes in body composition of healthy and osteoporotic women. Maturitas 1997, 27:25-33.
22. Schott A.M., Cormier C., Hans D., et al. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study. Osteoporos Int 1998, 8:247-254.
23. Gnudi S., Sitta E., Fiumi N. Relationship between body composition and bone mineral density in women with and without osteoporosis: relative contribution of lean and fat mass. J Bone Miner Metab 2007, 25:326-332.
24. Hsu Y.H., Venners S.A., Terwedow H.A., et al. Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 2006, 83:146-154.
25. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, Geneva: WHO, 1994.
26. Forsling ML Diurnal rhythms in neurohypophysial function. Exp Physiol 2000, 85:179S-186S.
27. Reid I.R. Relationships between fat and bone. Osteoporos Int 2008, 19:595-606.
28. Abe E., Sun L., Mechanick J., et al. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Ann N Y Acad Sci 2007, 1116:383-391.
29. Murphy E., Gluer C.C., Reid D.M., et al. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab 2010, 95:3173-3181.
30. Prior J.C. FSH and bone--important physiology or not?. Trends Mol Med 2007, 13:1-3.
31. Xu Z.R., Wang A.H., Wu X.P., et al. Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. Clin Chim Acta 2009, 400:8-13.
32. Lane N.E. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006, 194:S3-S11.
33. Liu S.Z., Tian L.F., Xu P., et al. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women. Mol Biol Rep 2011, 38(2):939-948.
34. Hoppe E., Bouvard B., Royer M., et al. Sex hormone-binding globulin in osteoporosis. Joint Bone Spine 2010, 77:306-312.
35. Takeda S. Central control of bone remodelling. J Neuroendocrinol 2008, 20:802-807.
36. Grigorie D., Neacsu E., Marinescu M., et al. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis. Rom J Intern Med 2003, 41:409-415.
37. Goulding A., Taylor R.W. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 1998, 63:456-458.